Oncology Clinical Trials in El Paso, TX
As of August 2026, 25 paid clinical trials are recruiting for Oncology in El Paso, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
25 clinical trials for Oncology
·Clear filters·Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Multi-analyte Blood Test Clinical Trial
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Project: Every Child for Younger Patients With Cancer
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Top Research Study Locations in El Paso
Researchers run research studies in El Paso, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| El Paso Children's Hospital | B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm, Acute Myeloid Leukemia | 22 |
| ANESC Research | Focal Epilepsy, Acute Treatment of Migraine, Agitation | 10 |
| Texas Oncology - West Texas | Breast Neoplasms, Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung | 5 |
| Renovatio Clinical - El Paso | Non-Small Cell Lung Cancer, Cancer, Carcinoma, Non-Small-Cell Lung | 5 |
| Texas Arthritis Center | Juvenile Psoriatic Arthritis, Lupus Erythematosus, Systemic, Lupus Nephritis | 4 |
| University of Texas at El Paso | Insulin Resistance, Activity Trackers, Obesity | 3 |
| David Turbay, MD | Obesity, Atherosclerotic Cardiovascular Disease, Heart Failure | 3 |
| GSK Investigational Site | HIV Infections, Pulmonary Disease, Chronic Obstructive, Scleroderma, Systemic | 3 |
| Proactive El Paso,LLC | Alagille Syndrome, Moderately to Severely Active Crohns Disease, Pneumococcal Disease | 3 |
| University Medical Center of El Paso | Alcohol Use Disorder, Diabetes, Fracture Fixation, Internal | 3 |
| Western Sky Medical Research | Asthma, Chronic Spontaneous Urticaria, Chronic Spontaneous Urticaria (CSU) | 3 |
| El Paso Eye Surgeons | Open-Angle Glaucoma, Primary Open Angle Glaucoma | 3 |
| 3A Research - East El Paso | Migraine, Episodic Migraine, Migraine Prophylaxis | 3 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 2 |
| 3A Research | Chronic Idiopathic Constipation (CIC), Severe Alopecia Areata | 2 |
| 3A Research Llc West Location | Hidradenitis Suppurativa (HS), NonSegmental Vitiligo | 2 |
| Academy Of Diabetes, Thyroid And Endocrine, PA | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 2 |
| Advanced Neurology Epilepsy and Sleep Center ANESC | Obesity, Obstructive Sleep Apnoea, Overweight | 2 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| Biorhythms Center for Integrative Sleep Medicine | Obesity, Obstructive Sleep Apnoea, Overweight | 2 |
| Department of Physical Therapy and Movement Science, University of Texas at El Paso | Healthy Adult | 2 |
| El Paso Medical Research Institute (Medresearch Inc) | Cancer-Associated Thrombosis (CAT), Venous Thromboembolism (VTE) | 2 |
| El Paso Texas Oncology | Early Breast Cancer, Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors | 2 |
| Haracec Clinical Research | Post Traumatic Stress Disorder, Schizophrenia | 2 |
| Rio Grande Urology | Oligometastatic Prostate Cancer (OMPC), PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy | 2 |
Active & Upcoming Studies in El Paso (2026)
Recruiting trials in El Paso grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (31 active studies)
- REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis · Phase 3 · Regeneron Pharmaceuticals
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · Phase 3 · Pfizer
Neurology & pain (22 active studies)
- AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea · Phase 3 · Novo Nordisk A/S
- AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea · Phase 3 · Novo Nordisk A/S
Diabetes & metabolic (11 active studies)
Cardiovascular (11 active studies)
Eye & vision (4 active studies)
- A Study of Outcomes Following Bio-Reinforced Canaloplasty in Eyes With Open-Angle Glaucoma · Iantrek, Inc.
- Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant · Phase 2, Phase 3 · Glaukos Corporation
Mental health & behavior (3 active studies)
HIV / STI (1 active study)
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in El Paso
- Asthma (6 active studies)
- Obesity (6 active studies)
- Alzheimer Disease (4 active studies)
- Overweight (4 active studies)
- B Acute Lymphoblastic Leukemia (3 active studies)
- Graves' Disease (3 active studies)
Leading research sponsors in El Paso
- AstraZeneca
- Children's Oncology Group
- University of Texas, El Paso
- National Cancer Institute (NCI)
- Novartis Pharmaceuticals
Frequently asked questions
How many paid clinical trials are currently recruiting in El Paso?
There are approximately 182 recruiting clinical trials in El Paso, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in El Paso pay participants?
Most recruiting trials in El Paso compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in El Paso?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in El Paso?
The most common conditions under active study in El Paso include Asthma (6), Obesity (6), Alzheimer Disease (4), Overweight (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in El Paso?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in El Paso on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in El Paso?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in El Paso?
Recruiting research sites in El Paso include El Paso Children's Hospital, ANESC Research, Texas Oncology - West Texas, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in El Paso right now?
The largest active categories in El Paso are Cancer & tumors (31), Neurology & pain (22), Diabetes & metabolic (11). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.